ETERNA THERAPEUTICS INC shareholders Q2 2023

ETERNA THERAPEUTICS INC's ticker is and the CUSIP is 114082209. A total of 21 filers reported holding ETERNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

ETERNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Cypress Point Wealth Management, LLC 94,375$213,2880.23%
Naviter Wealth, LLC 80,396$181,6950.05%
Sippican Capital Advisors 21,601$48,8180.04%
BALDWIN BROTHERS LLC/MA 9,470$21,4020.00%
FMR LLC 1$20.00%
WELLS FARGO & COMPANY/MN 33$750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 19$420.00%
GEODE CAPITAL MANAGEMENT, LLC 13,691$30,3940.00%
MONTAG A & ASSOCIATES INC 70$1590.00%
CITIGROUP INC 15$330.00%
GOLDMAN SACHS GROUP INC 11,284$25,5020.00%
MORGAN STANLEY 50$1130.00%
BlackRock Inc. 17,772$40,1650.00%
Carmichael Hill & Associates, Inc. 75$1700.00%
Aspire Private Capital, LLC 10$230.00%
Tower Research Capital LLC (TRC) 5,031$11,3700.00%
Corient Private Wealth LLC 60,275$133,8110.00%
JPMORGAN CHASE & CO 14$310.00%
ROYAL BANK OF CANADA 53$00.00%

This page lists ETERNA THERAPEUTICS INC's shareholders in Q2 2023. To view ETERNA THERAPEUTICS INC's shareholder history, click here.